Logo image of NRX.CA

NUREXONE BIOLOGIC INC (NRX.CA) Stock Analyst Ratings

Canada - TSX Venture Exchange - TSX-V:NRX - CA67059R1091 - Common Stock

0.66 CAD
0 (0%)
Last: 1/21/2026, 7:00:00 PM
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to NRX.CA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 3.57. This target is 440.91% above the current price.
  • NRX.CA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NRX.CA.
  • In the previous month the buy percentage consensus was at a similar level.
  • NRX.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

NRX.CA Historical Analyst RatingsNRX.CA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -27 -24 -21 -18 -15 -12 -9 -6 -3 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.663.543.573.573.68 - 435.61% 440.91% 440.91% 456.82%

Related screens

NRX.CA Current Analyst RatingNRX.CA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

NUREXONE BIOLOGIC INC / NRX.CA FAQ

What is the price target for NRX stock?

9 analysts have analysed NRX.CA and the average price target is 3.57 CAD. This implies a price increase of 440.91% is expected in the next year compared to the current price of 0.66.


What is the consensus rating for NUREXONE BIOLOGIC INC (NRX.CA) stock?

The consensus rating for NUREXONE BIOLOGIC INC (NRX.CA) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.